Literature DB >> 1654443

A bovine papillomavirus E1-related protein binds specifically to bovine papillomavirus DNA.

V G Wilson1, J Ludes-Meyers.   

Abstract

The E1 open reading frame of bovine papillomavirus (BPV) was expressed as a RecA-E1 fusion protein in Escherichia coli. The bacterially expressed RecA-E1 protein exhibited sequence-specific DNA binding activity; strong binding to the region from nucleotides 7819 to 93 on the BPV genome (designated region A) and weak binding to the adjacent region from nucleotides 7457 to 7818 (region B) were observed. The interaction between the BPV-derived RecA-E1 protein and region A appeared to be highly specific for BPV DNA, as no comparable binding was detected with heterologous papillomavirus DNAs. Binding to region A was eliminated by digestion of region A at the unique HpaI site, which suggests that the RecA-E1 binding site(s) was at or near the HpaI recognition sequence. Binding to region B but not region A was observed when nuclear extracts from ID13 cells were used as a source of E1 proteins. The absence of region A binding by ID13 extracts may reflect a negative regulation of E1 DNA binding activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654443      PMCID: PMC249011     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator.

Authors:  I J Mohr; R Clark; S Sun; E J Androphy; P MacPherson; M R Botchan
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

2.  Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor.

Authors:  L Berg; M Lusky; A Stenlund; M R Botchan
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  Complementation of a bovine papilloma virus low-copy-number mutant: evidence for a temporal requirement of the complementing gene.

Authors:  L J Berg; K Singh; M Botchan
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

4.  The product of the bovine papillomavirus type 1 modulator gene (M) is a phosphoprotein.

Authors:  L Thorner; N Bucay; J Choe; M Botchan
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

5.  A bovine papillomavirus type 1-encoded modulator function is dispensable for transient viral replication but is required for establishment of the stable plasmid state.

Authors:  M Lusky; M R Botchan
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells.

Authors:  S Santucci; E J Androphy; C Bonne-Andréa; P Clertant
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Transient replication of bovine papilloma virus type 1 plasmids: cis and trans requirements.

Authors:  M Lusky; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Bovine papillomavirus type 1 E1 replication-defective mutants are altered in their transcriptional regulation.

Authors:  P F Lambert; P M Howley
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Promoters of bovine papillomavirus type 1: in vitro activity and utilization.

Authors:  U Linz; C C Baker
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Detection of a murine coronavirus nonstructural protein encoded in a downstream open reading frame.

Authors:  J L Leibowitz; S Perlman; G Weinstock; J R DeVries; C Budzilowicz; J M Weissemann; S R Weiss
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

View more
  52 in total

1.  A ring-opening mechanism for DNA binding in the central channel of the T7 helicase-primase protein.

Authors:  P Ahnert; K M Picha; S S Patel
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  A superfamily 3 DNA helicase encoded by plasmid pSSVi from the hyperthermophilic archaeon Sulfolobus solfataricus unwinds DNA as a higher-order oligomer and interacts with host primase.

Authors:  Xin Guo; Li Huang
Journal:  J Bacteriol       Date:  2010-01-29       Impact factor: 3.490

3.  Identification of a short, hydrophilic amino acid sequence critical for origin recognition by the bovine papillomavirus E1 protein.

Authors:  A Gonzalez; C Bazaldua-Hernandez; M West; K Woytek; V G Wilson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Bovine papillomavirus type 1 E1 and simian virus 40 large T antigen share regions of sequence similarity required for multiple functions.

Authors:  K C Mansky; A Batiza; P F Lambert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 5.  Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.

Authors:  Domenico Mattoscio; Chiara V Segré; Susanna Chiocca
Journal:  World J Virol       Date:  2013-05-12

6.  The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities.

Authors:  J Sedman; A Stenlund
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  Characterization of the DNA-binding domain of the bovine papillomavirus replication initiator E1.

Authors:  G Chen; A Stenlund
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Transient viral DNA replication and repression of viral transcription are supported by the C-terminal domain of the bovine papillomavirus type 1 E1 protein.

Authors:  M C Ferran; A A McBride
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  E1 protein of human papillomavirus is a DNA helicase/ATPase.

Authors:  F J Hughes; M A Romanos
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

10.  Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein.

Authors:  M G Frattini; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.